Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Metastasis From Malignant Tumor of Prostate”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00083005
What this trial is testing

Docetaxel, Estramustine, and Thalidomide in Treating Patients With Androgen-Independent Metastatic Adenocarcinoma of the Prostate

Who this might be right for
Prostate Cancer
National Institutes of Health Clinical Center (CC) 60
Not applicableStudy completedNCT04533958
What this trial is testing

Evaluation of Hypnosis in Virtual Reality on the Anxiety of Patients With Metastatic Prostate Cancer Over Chemotherapy

Who this might be right for
Metastatic Prostate Cancer
Saint-Gregoire Private Hospital Center 53
Testing effectiveness (Phase 2)Active Not RecruitingNCT03456843
What this trial is testing

Therapeutic Effect of Cytoreductive Radical Prostatectomy in Men With Newly Diagnosed Metastatic Prostate Cancer

Who this might be right for
Stage IV Prostate Adenocarcinoma AJCC v7
Yale University 190
Large-scale testing (Phase 3)Study completedNCT00255606
What this trial is testing

Docetaxel and Prednisone in Treating Patients With Hormone-Refractory Metastatic Prostate Cancer

Who this might be right for
Prostate Cancer
Tampere University 360
Testing effectiveness (Phase 2)Looking for participantsNCT07650240
What this trial is testing

Study of PSMA-targeted Therapy and Androgen Receptor Suppression in Low-volume Metastatic ProstatE Cancer: SPARKLE Trial

Who this might be right for
Recurrent Prostate AdenocarcinomaStage IVB Prostate Cancer AJCC v8Castration-Sensitive Prostate Cancer+9 more
Mayo Clinic 202
Not applicableNo Longer AvailableNCT04854369
What this trial is testing

68Ga-PSMA-11 Patients With Newly Diagnosed and Recurrent Prostate Cancer (Firefly)

Who this might be right for
Prostatic NeoplasmsProstatic Neoplasms, Castration-Resistant
Tulane University
Large-scale testing (Phase 3)Looking for participantsNCT06439225
What this trial is testing

Platinum and Taxane Chemo in Met Castration Resistant Prostate Cancer Patients With Alterations in DNA Damage Response Genes

Who this might be right for
Metastatic Castration-resistant Prostate CancerMetastatic Prostate Cancer
Canadian Cancer Trials Group 236
Testing effectiveness (Phase 2)Study completedNCT00433446
What this trial is testing

S0354, Anti-IL-6 Chimeric Monoclonal Antibody in Patients With Metastatic Prostate Cancer That Did Not Respond to Hormone Therapy

Who this might be right for
Prostate Cancer
SWOG Cancer Research Network 62
Not applicableLooking for participantsNCT06469710
What this trial is testing

A Trial to Evaluate the Effect of Applying Leukapheresis to Enrich CTCs in mPCa Patients

Who this might be right for
Prostate CancerCirculating Tumor CellLeukapheresis
RenJi Hospital 50
Testing effectiveness (Phase 2)WithdrawnNCT02065323
What this trial is testing

Dovitinib With Androgen Deprivation Therapy (ADT) in Patients With Metastatic Prostate Cancer Receiving Primary ADT

Who this might be right for
Prostate Cancer
Oscar Goodman, Jr.
Testing effectiveness (Phase 2)Study completedNCT00258284
What this trial is testing

Capecitabine and Docetaxel in Treating Patients With Metastatic Prostate Cancer

Who this might be right for
Prostate Cancer
Barbara Ann Karmanos Cancer Institute 30
Not applicableStudy completedNCT06238596
What this trial is testing

Rehabilitation Intervention to Prevent Adverse Events Related to Androgen-deprivation Therapy (ADT) in Patients With Metastatic Prostate Cancer (PCa): a Single Arm Feasibility Study (ReCaP Study)

Who this might be right for
Metastatic Prostate Cancer (PCa) in ADTRehabilitation
Azienda USL Reggio Emilia - IRCCS 40
Testing effectiveness (Phase 2)UnknownNCT06081686
What this trial is testing

Study of [177Lu] Lu-XT033 Injection in Patients With Metastatic Prostate Cancer

Who this might be right for
Prostate Cancer
Sinotau Pharmaceutical Group 32
Large-scale testing (Phase 3)Study completedNCT00779402
What this trial is testing

PROvenge Treatment and Early Cancer Treatment

Who this might be right for
Prostate Cancer
Dendreon 176
Testing effectiveness (Phase 2)Study completedNCT00174863
What this trial is testing

Evaluation of SR 31747A Versus Placebo in Androgen-Independent Non Metastatic Prostate Cancer

Who this might be right for
Prostatic Neoplasm
Sanofi 232
Early research (Phase 1)Ended earlyNCT01262664
What this trial is testing

A First-in-Man, Phase I Evaluation of A Single Cycle of Prohibitin Targeting Peptide 1 in Patients With Metastatic Prostate Cancer and Obesity

Who this might be right for
Prostate Cancer
M.D. Anderson Cancer Center 4
Very early researchLooking for participantsNCT05802121
What this trial is testing

Akkermansia Muciniphilia and Metabolic Side Effects of ADT

Who this might be right for
Prostate CancerMetabolic SyndromeObesity+4 more
Western University 30
Testing effectiveness (Phase 2)Looking for participantsNCT07192614
What this trial is testing

Learn How Safe AZD6621 is, How Well it Works, and How it Moves Throughout the Body Over Time, in Adult Male Participants With Metastatic Prostate Cancer

Who this might be right for
Prostate Cancer
AstraZeneca 52
Early research (Phase 1)Looking for participantsNCT05800665
What this trial is testing

A Study Evaluating the Safety, Pharmacokinetics, and Activity of RO7656594 In Participants With Advanced or Metastatic Prostate Cancer

Who this might be right for
Advanced Prostate CancerMetastatic Prostate Cancer
Genentech, Inc. 210
Testing effectiveness (Phase 2)Looking for participantsNCT06582628
What this trial is testing

Talazoparib Plus Enzalutamide After Progression to Abiraterone in Metastatic Prostate Cancer: (TEAM PC)

Who this might be right for
Metastatic Prostate Cancer
Fundacion Oncosur 78
Next Page